{"id":70496,"date":"2026-07-23T21:33:01","date_gmt":"2026-07-23T13:33:01","guid":{"rendered":"https:\/\/flcube.com\/?p=70496"},"modified":"2026-07-23T21:33:01","modified_gmt":"2026-07-23T13:33:01","slug":"johnson-johnson-secures-fda-de-novo-authorization-for-ottava-worlds-first-table-integrated-robotic-surgical-system","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=70496","title":{"rendered":"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World’s First Table-Integrated Robotic Surgical System"},"content":{"rendered":"\n

Johnson & Johnson<\/strong> (NYSE: JNJ<\/a>) announced on July 22, 2026 that the U.S. Food and Drug Administration (FDA)<\/strong> has granted De Novo authorization<\/strong> for the OTTAVA\u2122 Robotic Surgical System<\/strong>, establishing the world’s first table-integrated soft tissue robotic platform<\/strong>. The system received marketing authorization for ten general surgery procedures, marking Johnson & Johnson’s strategic entry into the surgical robotics market with a fundamentally reimagined architectural approach.<\/p>\n\n\n\n

Regulatory Milestone<\/h2>\n\n\n\n
Parameter<\/th>Detail<\/th><\/tr><\/thead>
Company<\/strong><\/td>Johnson & Johnson (NYSE: JNJ)<\/td><\/tr>
Regulatory Pathway<\/strong><\/td>FDA De Novo authorization (novel device without predicate)<\/td><\/tr>
Approval Date<\/strong><\/td>22 Jul 2026<\/td><\/tr>
Device<\/strong><\/td>OTTAVA\u2122 Robotic Surgical System<\/td><\/tr>
Classification<\/strong><\/td>World’s first table-integrated soft tissue robotic system<\/td><\/tr>
Authorized Indications<\/strong><\/td>10 general surgery procedures<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Authorized Surgical Procedures<\/h2>\n\n\n\n

The OTTAVA system is cleared for the following general surgery indications:<\/p>\n\n\n\n

    \n
  • Roux-en-Y gastric bypass<\/li>\n\n\n\n
  • Gastrectomy<\/li>\n\n\n\n
  • Cholecystectomy<\/li>\n\n\n\n
  • Splenectomy<\/li>\n\n\n\n
  • Gastric sleeve<\/li>\n\n\n\n
  • Small bowel resection<\/li>\n\n\n\n
  • Appendectomy<\/li>\n\n\n\n
  • Lysis of adhesions<\/li>\n\n\n\n
  • Fundoplication<\/li>\n\n\n\n
  • Hiatal hernia repair<\/li>\n<\/ul>\n\n\n\n

    Additional indications under development, including ongoing U.S. clinical trial for inguinal hernia procedures<\/em><\/p>\n\n\n\n

    System Architecture & Innovation<\/h2>\n\n\n\n

    Space-Efficient Design<\/h3>\n\n\n\n
      \n
    • Smallest multi-port soft-tissue robotic footprint<\/strong>: Integrates robotic arms directly into OR table<\/li>\n\n\n\n
    • 30\u201350% less space<\/strong> than traditional boom- and cart-mounted systems<\/li>\n\n\n\n
    • Enhanced surgeon and clinical team mobility with improved communication pathways<\/li>\n<\/ul>\n\n\n\n

      Automation & Workflow Enhancement<\/h3>\n\n\n\n
        \n
      • Four table-integrated arms<\/strong> with sophisticated software coordination<\/li>\n\n\n\n
      • Automated, pre-defined procedural poses<\/strong> simplify setup and breakdown<\/li>\n\n\n\n
      • Twin motion technology<\/strong>: Synchronized table and arm movement enables seamless patient repositioning and multi-quadrant anatomical access<\/li>\n<\/ul>\n\n\n\n

        Purpose-Built Instrumentation<\/h3>\n\n\n\n
          \n
        • Two-in-one needle driver<\/strong>: Reduces unintended suture cutting<\/li>\n\n\n\n
        • Monopolar curved scissors<\/strong>: Ensures consistent and complete tissue cuts<\/li>\n\n\n\n
        • Portfolio reimagined based on generations of open and laparoscopic surgical experience<\/li>\n<\/ul>\n\n\n\n

          Digital Ecosystem Integration<\/h3>\n\n\n\n
            \n
          • Polyphonic\u2122 for OTTAVA\u2122<\/strong>: Secure digital solution integrating learning, media, and data-driven insights<\/li>\n\n\n\n
          • Supports continuous improvement across the surgical journey<\/li>\n\n\n\n
          • Foundation for future digitally enabled, data-driven surgery<\/li>\n<\/ul>\n\n\n\n

            Commercial Strategy & Market Impact<\/h2>\n\n\n\n
              \n
            • Phased Launch<\/strong>: Initial commercial rollout with select U.S. customers focused on early success validation<\/li>\n\n\n\n
            • Global Expansion<\/strong>: Parallel development for additional indications and international regulatory jurisdictions<\/li>\n\n\n\n
            • Market Entry<\/strong>: Strategic positioning in the $8.5 billion global surgical robotics market<\/li>\n\n\n\n
            • Competitive Differentiation<\/strong>: Addresses key adoption barriers including space constraints, workflow complexity, and total cost of ownership<\/li>\n<\/ul>\n\n\n\n

              Executive Perspective<\/h3>\n\n\n\n
              \n

              “We are pioneering a new category of surgical robotics with OTTAVA,” said Tim Schmid, Executive Vice President, Worldwide Chairman, MedTech, Johnson & Johnson. “This is the start of the next era in surgery as we deliver not just a new surgical robotics system, but a catalyst for fundamentally better surgical care.”<\/p>\n\n\n\n

              “Surgical robotics will play an increasingly important role in surgical care, but it’s clear that what defined the last 25 years of surgery will not define the next 25,” added Hani Abouhalka, Company Group Chair, Surgery, MedTech, Johnson & Johnson.<\/p>\n<\/blockquote>\n\n\n\n

              Clinical Support & Education<\/h2>\n\n\n\n
                \n
              • Comprehensive Training Program<\/strong>: Virtual, hands-on, and immersive training developed with clinicians and surgical societies<\/li>\n\n\n\n
              • Legacy Backing<\/strong>: Supported by Johnson & Johnson’s established continuous education infrastructure<\/li>\n\n\n\n
              • Safe Adoption Framework<\/strong>: Designed to ensure consistent performance for both new and experienced robotic surgeons<\/li>\n<\/ul>\n\n\n\n

                Forward\u2011Looking Statements<\/strong>
                This brief contains forward-looking statements regarding regulatory approvals, commercial launches, clinical trials, and market opportunities. Actual results may differ due to risks including commercial implementation timelines, regulatory requirements in other jurisdictions, competitive dynamics, and clinical trial outcomes.<\/p>\n","protected":false},"excerpt":{"rendered":"

                Johnson & Johnson (NYSE: JNJ) announced on July 22, 2026 that the U.S. Food and…<\/p>\n","protected":false},"author":1,"featured_media":70497,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[22],"tags":[149,858,15],"class_list":["post-70496","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-device","tag-johnson-johnson","tag-nyse-jnj","tag-product-approvals"],"yoast_head":"\nJohnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World's First Table-Integrated Robotic Surgical System - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Johnson & Johnson (NYSE: JNJ) announced on July 22, 2026 that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA\u2122 Robotic Surgical System, establishing the world's first table-integrated soft tissue robotic platform. The system received marketing authorization for ten general surgery procedures, marking Johnson & Johnson's strategic entry into the surgical robotics market with a fundamentally reimagined architectural approach.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=70496\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World's First Table-Integrated Robotic Surgical System\" \/>\n<meta property=\"og:description\" content=\"Johnson & Johnson (NYSE: JNJ) announced on July 22, 2026 that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA\u2122 Robotic Surgical System, establishing the world's first table-integrated soft tissue robotic platform. The system received marketing authorization for ten general surgery procedures, marking Johnson & Johnson's strategic entry into the surgical robotics market with a fundamentally reimagined architectural approach.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=70496\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-23T13:33:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2301.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World’s First Table-Integrated Robotic Surgical System\",\"datePublished\":\"2026-07-23T13:33:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496\"},\"wordCount\":536,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/2301.webp\",\"keywords\":[\"Johnson & Johnson\",\"NYSE: JNJ\",\"Product approvals\"],\"articleSection\":[\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=70496#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=70496\",\"name\":\"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World's First Table-Integrated Robotic Surgical System - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/2301.webp\",\"datePublished\":\"2026-07-23T13:33:01+00:00\",\"description\":\"Johnson & Johnson (NYSE: JNJ) announced on July 22, 2026 that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA\u2122 Robotic Surgical System, establishing the world's first table-integrated soft tissue robotic platform. The system received marketing authorization for ten general surgery procedures, marking Johnson & Johnson's strategic entry into the surgical robotics market with a fundamentally reimagined architectural approach.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=70496\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/2301.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/2301.webp\",\"width\":1080,\"height\":608,\"caption\":\"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World's First Table-Integrated Robotic Surgical System\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70496#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World’s First Table-Integrated Robotic Surgical System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World's First Table-Integrated Robotic Surgical System - Insight, China's Pharmaceutical Industry","description":"Johnson & Johnson (NYSE: JNJ) announced on July 22, 2026 that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA\u2122 Robotic Surgical System, establishing the world's first table-integrated soft tissue robotic platform. The system received marketing authorization for ten general surgery procedures, marking Johnson & Johnson's strategic entry into the surgical robotics market with a fundamentally reimagined architectural approach.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=70496","og_locale":"en_US","og_type":"article","og_title":"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World's First Table-Integrated Robotic Surgical System","og_description":"Johnson & Johnson (NYSE: JNJ) announced on July 22, 2026 that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA\u2122 Robotic Surgical System, establishing the world's first table-integrated soft tissue robotic platform. The system received marketing authorization for ten general surgery procedures, marking Johnson & Johnson's strategic entry into the surgical robotics market with a fundamentally reimagined architectural approach.","og_url":"https:\/\/flcube.com\/?p=70496","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-07-23T13:33:01+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2301.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=70496#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=70496"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World’s First Table-Integrated Robotic Surgical System","datePublished":"2026-07-23T13:33:01+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=70496"},"wordCount":536,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=70496#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2301.webp","keywords":["Johnson & Johnson","NYSE: JNJ","Product approvals"],"articleSection":["Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=70496#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=70496","url":"https:\/\/flcube.com\/?p=70496","name":"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World's First Table-Integrated Robotic Surgical System - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=70496#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=70496#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2301.webp","datePublished":"2026-07-23T13:33:01+00:00","description":"Johnson & Johnson (NYSE: JNJ) announced on July 22, 2026 that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA\u2122 Robotic Surgical System, establishing the world's first table-integrated soft tissue robotic platform. The system received marketing authorization for ten general surgery procedures, marking Johnson & Johnson's strategic entry into the surgical robotics market with a fundamentally reimagined architectural approach.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=70496#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=70496"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=70496#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2301.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2301.webp","width":1080,"height":608,"caption":"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World's First Table-Integrated Robotic Surgical System"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=70496#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Johnson & Johnson Secures FDA De Novo Authorization for OTTAVA\u2122 \u2013 World’s First Table-Integrated Robotic Surgical System"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2301.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/70496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=70496"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/70496\/revisions"}],"predecessor-version":[{"id":70498,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/70496\/revisions\/70498"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/70497"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=70496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=70496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=70496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}